Abstract
Although Dopamine and cAMP-regulated phosphoprotein, Mr 32000 (DARPP-32) is overexpressed in twothirds of gastric cancers, its impact on molecular functions has not been fully characterized. In this study, we examined the role of DARPP-32 in gastric cancer cell invasion. Using matrigel-coated Boyden chamber invasion assay,DARPP-32-overexpressingAGScells showed a three-fold increase in invasion relative to the vector control (P < 0.01). We also tested the transendothelial cell invasion as a measure of cell aggressiveness using the impedance-based human umbilical vein endothelial cells invasion assay and obtained similar results (P < 0.001). Western blot analysis indicated that overexpression of DARPP-32 mediated an increase in the membrane-type 1 matrix metalloproteinase (MT1-MMP) and CXCR4 protein levels. Consistent with the role of MT1-MMP in cleaving extracellular matrix proteins initiating the activation of solubleMMPs, we detected a robust increase inMMP-2 activity in DARPP-32- overexpressing cells. The knockdown of endogenousDARPP-32 in theMKN-45 cells reversed these signaling events and decreased cell invasive activity. We tested whether the invasive activity mediated by DARPP-32 might involve sustained signaling via CXCR4-dependent activation of the MT1-MMP/MMP-2 pathway. The small-molecule CXCR4 antagonist (AMD3100) and CXCR4-siRNA blocked DARPP-32-induced cell invasion. We further examined our hypothesis that DARPP-32 could interact with CXCR4 and stabilize its levels following stimulation with its ligand, CXCL12. Using reciprocal coimmunoprecipitation and immunofluorescence experiments, we found thatDARPP-32 andCXCR4 coexist in the same protein complex.DARPP-32 prolonged theCXCR4 protein half-life and reduced ubiquitination of the CXCR4 protein, following treatment with its ligand, CXCL12. In conclusion, these findings show a novel mechanism by which DARPP-32 promotes cell invasion by regulating CXCR4-mediated activation of the MT1-MMP/MMP-2 pathway.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 86-94 |
| Number of pages | 9 |
| Journal | Molecular Cancer Research |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2013 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Molecular Biology
- Oncology
- Cancer Research
Cite this
Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. / Zhu, Shoumin; Hong, Jun; Tripathi, Manish K.; Sehdev, Vikas; Belkhiri, Abbes; El-Rifai, Wael.
In: Molecular Cancer Research, Vol. 11, No. 1, 01.01.2013, p. 86-94.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells
AU - Zhu, Shoumin
AU - Hong, Jun
AU - Tripathi, Manish K.
AU - Sehdev, Vikas
AU - Belkhiri, Abbes
AU - El-Rifai, Wael
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Although Dopamine and cAMP-regulated phosphoprotein, Mr 32000 (DARPP-32) is overexpressed in twothirds of gastric cancers, its impact on molecular functions has not been fully characterized. In this study, we examined the role of DARPP-32 in gastric cancer cell invasion. Using matrigel-coated Boyden chamber invasion assay,DARPP-32-overexpressingAGScells showed a three-fold increase in invasion relative to the vector control (P < 0.01). We also tested the transendothelial cell invasion as a measure of cell aggressiveness using the impedance-based human umbilical vein endothelial cells invasion assay and obtained similar results (P < 0.001). Western blot analysis indicated that overexpression of DARPP-32 mediated an increase in the membrane-type 1 matrix metalloproteinase (MT1-MMP) and CXCR4 protein levels. Consistent with the role of MT1-MMP in cleaving extracellular matrix proteins initiating the activation of solubleMMPs, we detected a robust increase inMMP-2 activity in DARPP-32- overexpressing cells. The knockdown of endogenousDARPP-32 in theMKN-45 cells reversed these signaling events and decreased cell invasive activity. We tested whether the invasive activity mediated by DARPP-32 might involve sustained signaling via CXCR4-dependent activation of the MT1-MMP/MMP-2 pathway. The small-molecule CXCR4 antagonist (AMD3100) and CXCR4-siRNA blocked DARPP-32-induced cell invasion. We further examined our hypothesis that DARPP-32 could interact with CXCR4 and stabilize its levels following stimulation with its ligand, CXCL12. Using reciprocal coimmunoprecipitation and immunofluorescence experiments, we found thatDARPP-32 andCXCR4 coexist in the same protein complex.DARPP-32 prolonged theCXCR4 protein half-life and reduced ubiquitination of the CXCR4 protein, following treatment with its ligand, CXCL12. In conclusion, these findings show a novel mechanism by which DARPP-32 promotes cell invasion by regulating CXCR4-mediated activation of the MT1-MMP/MMP-2 pathway.
AB - Although Dopamine and cAMP-regulated phosphoprotein, Mr 32000 (DARPP-32) is overexpressed in twothirds of gastric cancers, its impact on molecular functions has not been fully characterized. In this study, we examined the role of DARPP-32 in gastric cancer cell invasion. Using matrigel-coated Boyden chamber invasion assay,DARPP-32-overexpressingAGScells showed a three-fold increase in invasion relative to the vector control (P < 0.01). We also tested the transendothelial cell invasion as a measure of cell aggressiveness using the impedance-based human umbilical vein endothelial cells invasion assay and obtained similar results (P < 0.001). Western blot analysis indicated that overexpression of DARPP-32 mediated an increase in the membrane-type 1 matrix metalloproteinase (MT1-MMP) and CXCR4 protein levels. Consistent with the role of MT1-MMP in cleaving extracellular matrix proteins initiating the activation of solubleMMPs, we detected a robust increase inMMP-2 activity in DARPP-32- overexpressing cells. The knockdown of endogenousDARPP-32 in theMKN-45 cells reversed these signaling events and decreased cell invasive activity. We tested whether the invasive activity mediated by DARPP-32 might involve sustained signaling via CXCR4-dependent activation of the MT1-MMP/MMP-2 pathway. The small-molecule CXCR4 antagonist (AMD3100) and CXCR4-siRNA blocked DARPP-32-induced cell invasion. We further examined our hypothesis that DARPP-32 could interact with CXCR4 and stabilize its levels following stimulation with its ligand, CXCL12. Using reciprocal coimmunoprecipitation and immunofluorescence experiments, we found thatDARPP-32 andCXCR4 coexist in the same protein complex.DARPP-32 prolonged theCXCR4 protein half-life and reduced ubiquitination of the CXCR4 protein, following treatment with its ligand, CXCL12. In conclusion, these findings show a novel mechanism by which DARPP-32 promotes cell invasion by regulating CXCR4-mediated activation of the MT1-MMP/MMP-2 pathway.
UR - http://www.scopus.com/inward/record.url?scp=84873022411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873022411&partnerID=8YFLogxK
U2 - 10.1158/1541-7786.MCR-12-0243-T
DO - 10.1158/1541-7786.MCR-12-0243-T
M3 - Article
C2 - 23160836
AN - SCOPUS:84873022411
VL - 11
SP - 86
EP - 94
JO - Molecular Cancer Research
JF - Molecular Cancer Research
SN - 1541-7786
IS - 1
ER -